Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331
Tumor Immunotherapy01:27

Tumor Immunotherapy

491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

158
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
158

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Quantum computing applications in drug discovery.

Briefings in bioinformatics·2026
Same author

A Multistage Virtual Screening Strategy Integrating Molecular Similarity, Deep Learning Scoring, and Molecular Docking toward the Discovery of Novel LRRK2 Inhibitors.

Journal of chemical information and modeling·2026
Same author

SMPD1-mediated sphingolipid metabolism dysregulation in predicting and preventing in-stent restenosis of coronary heart disease patients.

Journal of pharmaceutical analysis·2026
Same author

Integrated computational and experimental approaches for drug repurposing targeting key Mycobacterium tuberculosis proteins.

Molecular diversity·2026
Same author

Integrated multi-omics reveals population-specific mechanisms of cardiovascular disease in high-altitude environments.

iScience·2026
Same author

Enhancing ADMET property predictions using cross-aligned multimodal attention mechanisms.

Molecular diversity·2026

相关实验视频

Updated: Jun 12, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

使用scCURE构建免疫治疗结果预测模型的协议.

Yujun Liu1, Xin Zou2, Henry H Y Tong3

  • 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

STAR protocols
|December 11, 2024
PubMed
概括
此摘要是机器生成的。

预测癌症免疫治疗的成功是很困难的. 这项研究介绍了scCURE,这是一种使用单细胞RNA测序 (scRNA-seq) 来识别关键细胞的方法,可以更好地预测治疗结果.

关键词:
生物信息学是一种生物信息学.癌症 癌症 癌症 癌症健康科学 卫生科学 卫生科学

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

相关实验视频

Last Updated: Jun 12, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

科学领域:

  • 计算生物学 计算生物学
  • 免疫学 免疫学 免疫学
  • 基因组学就是基因组学.

背景情况:

  • 预测患者对癌症免疫疗法的反应仍然是一个重大的临床挑战.
  • 患者的基线状态不足以准确预测免疫治疗结果.
  • 需要新的计算方法来分析复杂的生物数据以进行预测建模.

研究的目的:

  • 引入一种新的协议,scCURE (基于单细胞RNA测序的免疫治疗期间改变和不改变的细胞识别),用于预测免疫治疗结果.
  • 详细说明使用scCURE.seq从scRNA-seq数据中识别不变细胞的方法.
  • 用scCURE识别的细胞从scRNA-seq和大量RNA测序 (RNA-seq) 数据中演示预测模型的构建.

主要方法:

  • 利用单细胞RNA测序 (scRNA-seq) 数据在免疫治疗期间识别具有稳定功能的细胞.
  • 开发了scCURE算法,以根据细胞和分子形状区分改变的和不改变的细胞.
  • 构建了免疫治疗结果的预测模型,利用scRNA-seq和大量RNA-seq数据集中识别的不变细胞.

主要成果:

  • 成功演示了一种识别免疫疗法反应至关重要的不变细胞的协议.
  • 建立了一个框架,以建立基于scCURE识别的细胞群的免疫疗法预测模型.
  • 展示了scCURE方法对scRNA-seq和大量RNA-seq数据分析的适用性.

结论:

  • scCURE协议提供了一种强大的方法来识别可以改善免疫治疗结果预测的关键细胞群.
  • 这种方法为增强个性化癌症治疗策略提供了有价值的工具.
  • 为了更广泛的临床应用,需要对scCURE进行进一步的研究和验证.